Champions Oncology earnings were -$1.2M for the trailing 12 months ending Apr 30, 2026, with N/A growth year over year. The latest CSBR earnings report on Apr 30, 2026 announced Q2 2026 earnings of -$667.0k, up 139.1% from last quarter. For the last reported fiscal year 2026 ending Apr 30, 2026, CSBR reported annual earnings of -$1.2M, with -125% growth. The next CSBR earnings date is Sep 21, 2026.
What were Champions Oncology's earnings last quarter?
On CSBR's earnings call on Mar 17, 2026, Champions Oncology (NASDAQ: CSBR) reported Q1 2026 earnings per share (EPS) of -$0.04, up 71.43% year over year. Total CSBR earnings for the quarter were -$667.00 thousand. In the same quarter last year, Champions Oncology's earnings per share (EPS) was -$0.14.
The next CSBR earnings date is Sep 21, 2026. Add CSBR to your watchlist to be reminded of Champions Oncology's next earnings date.
What was CSBR's earnings growth in the past year?
As of Champions Oncology's earnings date in Mar 17, 2026, Champions Oncology's earnings has grown year over year. CSBR earnings in the past year totalled -$1.18 million.
Is Champions Oncology profitable or losing money?
As of the last Champions Oncology earnings report, Champions Oncology is currently losing money. Champions Oncology's net profit (also called net income) for the twelve months ending Apr 30, 2026 was -$1.18 million, a 124.99% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.